SIMILAR PATTERNS OF AMINO ACIDS FOR 1HXB_A_ROCA100_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bg4 | ENDO-1,4-BETA-XYLANASE (Penicilliumsimplicissimum) |
PF00331(Glyco_hydro_10) | 5 | GLY A 19ASP A 7GLY A 78ILE A 81ILE A 37 | NoneGOL A 630 (-3.5A)NoneNoneNone | 0.88A | 1hxbA-1bg4A:undetectable | 1hxbA-1bg4A:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fob | BETA-1,4-GALACTANASE (Aspergillusaculeatus) |
PF07745(Glyco_hydro_53) | 5 | GLY A 40ALA A 39ASP A 38ILE A 44ILE A 328 | None | 0.88A | 1hxbA-1fobA:undetectable | 1hxbA-1fobA:14.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gae | D-GLYCERALDEHYDE-3-PHOSPHATEDEHYDROGENASE (Escherichiacoli) |
PF00044(Gp_dh_N)PF02800(Gp_dh_C) | 5 | ALA O 19VAL O 3ILE O 325ILE O 11ILE O 27 | NoneNoneNoneNAD O 336 (-3.9A)None | 0.86A | 1hxbA-1gaeO:undetectable | 1hxbA-1gaeO:15.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gom | ENDO-1,4-BETA-XYLANASE (Thermoascusaurantiacus) |
PF00331(Glyco_hydro_10) | 5 | GLY A 19ASP A 7GLY A 77ILE A 80ILE A 36 | None | 0.87A | 1hxbA-1gomA:undetectable | 1hxbA-1gomA:15.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28ASP A 29GLY A 48PRO A 81ILE A 84 | A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 (-4.1A)A79 A 800 ( 3.4A)A79 A 800 (-3.8A) | 0.82A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28ASP A 29VAL A 32GLY A 48ILE A 84 | A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.4A)A79 A 800 (-3.6A)A79 A 800 (-3.6A) | 0.71A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25ALA A 28ASP A 29GLY A 48GLY A 49ILE A 50 | A79 A 800 (-2.8A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 (-4.1A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A) | 1.47A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 48GLY A 49ILE A 50ILE A 84 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)A79 A 800 ( 4.4A)A79 A 800 ( 3.2A)A79 A 800 (-3.6A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A)A79 A 800 (-3.6A) | 0.45A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 12 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 ( 4.7A)A79 A 800 ( 4.3A)A79 A 800 ( 3.4A)A79 A 800 (-4.1A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A)A79 A 800 (-3.8A) | 0.47A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 48GLY A 49PRO A 81ILE A 84 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)A79 A 800 ( 4.4A)A79 A 800 ( 3.2A)A79 A 800 (-3.6A)A79 A 800 ( 3.7A)A79 A 800 ( 3.9A)A79 A 800 (-3.6A) | 0.45A | 1hxbA-1hvcA:14.0 | 1hxbA-1hvcA:48.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1j2q | PROTEASOME BETASUBUNIT (Archaeoglobusfulgidus) |
PF00227(Proteasome) | 5 | ALA H 38ILE H 101GLY H 102GLY H 103ILE H 104 | None | 0.85A | 1hxbA-1j2qH:undetectable | 1hxbA-1j2qH:18.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 84 | None | 0.50A | 1hxbA-1q9pA:10.5 | 1hxbA-1q9pA:93.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28VAL A 32PRO A 81ILE A 84 | None | 0.67A | 1hxbA-1q9pA:10.5 | 1hxbA-1q9pA:93.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r6b | CLPA PROTEIN (Escherichiacoli) |
PF00004(AAA)PF02861(Clp_N)PF07724(AAA_2)PF10431(ClpB_D2-small) | 5 | GLY X 406ALA X 405ILE X 433ILE X 399ILE X 426 | NoneNoneNoneADP X 780 (-4.7A)None | 0.88A | 1hxbA-1r6bX:undetectable | 1hxbA-1r6bX:9.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 6 | ASP A 25ALA A 28ASP A 29GLY A 48GLY A 49ILE A 50 | None | 1.36A | 1hxbA-1sivA:18.5 | 1hxbA-1sivA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | None | 0.52A | 1hxbA-1sivA:18.5 | 1hxbA-1sivA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tye | INTEGRIN BETA-3 (Homo sapiens) |
PF00362(Integrin_beta)PF17205(PSI_integrin) | 5 | GLY B 154ALA B 155GLY B 221GLY B 222ILE B 226 | None | 0.84A | 1hxbA-1tyeB:undetectable | 1hxbA-1tyeB:13.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xat | XENOBIOTICACETYLTRANSFERASE (Pseudomonasaeruginosa) |
PF00132(Hexapep) | 5 | GLY A 68ALA A 69ILE A 137GLY A 138ILE A 65 | None | 0.73A | 1hxbA-1xatA:undetectable | 1hxbA-1xatA:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xiw | IMMUNOGLOBULIN HEAVYCHAIN VARIABLEREGIONT-CELL SURFACEGLYCOPROTEIN CD3EPSILON CHAIN (Homo sapiens;Mus musculus) |
PF07686(V-set)PF16681(Ig_5) | 5 | ASP D 104GLY D 103ILE A 45GLY A 46GLY A 47 | None | 0.86A | 1hxbA-1xiwD:undetectable | 1hxbA-1xiwD:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y56 | HYPOTHETICAL PROTEINPH1363 (Pyrococcushorikoshii) |
PF07992(Pyr_redox_2)PF13510(Fer2_4) | 5 | ALA A 476ILE A 316GLY A 321GLY A 320ILE A 480 | None | 0.83A | 1hxbA-1y56A:undetectable | 1hxbA-1y56A:12.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yp4 | GLUCOSE-1-PHOSPHATEADENYLYLTRANSFERASESMALL SUBUNIT (Solanumtuberosum) |
PF00483(NTP_transferase) | 5 | GLY A 358ALA A 359ILE A 408GLY A 409ILE A 355 | None | 0.76A | 1hxbA-1yp4A:undetectable | 1hxbA-1yp4A:13.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ash | QUEUINETRNA-RIBOSYLTRANSFERASE (Thermotogamaritima) |
PF01702(TGT) | 5 | ASP A 142GLY A 92GLY A 242ILE A 214ILE A 182 | NoneNoneEDO A 404 ( 4.5A)EDO A 404 (-4.0A)None | 0.87A | 1hxbA-2ashA:undetectable | 1hxbA-2ashA:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bc0 | NADH OXIDASE (Streptococcuspyogenes) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | GLY A 453ALA A 454ASP A 456ILE A 387ILE A 426 | None | 0.69A | 1hxbA-2bc0A:undetectable | 1hxbA-2bc0A:12.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dws | COPPER-CONTAININGNITRITE REDUCTASE (Rhodobactersphaeroides) |
PF00394(Cu-oxidase)PF07732(Cu-oxidase_3) | 5 | GLY A 347ALA A 348ILE A 210ILE A 99PRO A 280 | None | 0.85A | 1hxbA-2dwsA:undetectable | 1hxbA-2dwsA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fko | 173AA LONGHYPOTHETICALFERRIPYOCHELINBINDING PROTEIN (Pyrococcushorikoshii) |
PF00132(Hexapep) | 5 | ALA A 89ILE A 74GLY A 75GLY A 92ILE A 103 | None | 0.79A | 1hxbA-2fkoA:undetectable | 1hxbA-2fkoA:21.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29VAL A 32ILE A 53GLY A 54GLY A 55PRO A 86ILE A 89 | LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)NoneLP1 A 201 (-4.6A)LP1 A 201 (-3.6A)LP1 A 201 (-3.4A)LP1 A 201 (-3.9A)LP1 A 201 (-4.2A) | 0.52A | 1hxbA-2fmbA:15.2 | 1hxbA-2fmbA:30.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2isq | CYSTEINE SYNTHASE (Arabidopsisthaliana) |
PF00291(PALP) | 5 | GLY A 190ALA A 189GLY A 183ILE A 180PRO A 296 | NoneNonePLP A 400 (-3.4A)PLP A 400 (-4.9A)PLP A 400 (-4.0A) | 0.77A | 1hxbA-2isqA:undetectable | 1hxbA-2isqA:15.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oqh | PUTATIVE ISOMERASE (Streptomycescoelicolor) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | GLY A 48ILE A 97GLY A 275GLY A 276ILE A 277 | None | 0.84A | 1hxbA-2oqhA:undetectable | 1hxbA-2oqhA:14.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q0l | THIOREDOXINREDUCTASE (Helicobacterpylori) |
PF07992(Pyr_redox_2) | 5 | ALA A 5VAL A 84ILE A 108GLY A 8ILE A 93 | NoneNoneNoneFAD A 400 (-3.2A)None | 0.83A | 1hxbA-2q0lA:undetectable | 1hxbA-2q0lA:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q50 | GLYOXYLATEREDUCTASE/HYDROXYPYRUVATE REDUCTASE (Homo sapiens) |
PF00389(2-Hacid_dh)PF02826(2-Hacid_dh_C) | 5 | GLY A 72VAL A 63ILE A 78GLY A 54ILE A 67 | None | 0.87A | 1hxbA-2q50A:undetectable | 1hxbA-2q50A:15.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qkx | BIFUNCTIONAL PROTEINGLMU (Mycobacteriumtuberculosis) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 5 | GLY A 334ALA A 335ILE A 366GLY A 367ILE A 331 | None | 0.73A | 1hxbA-2qkxA:undetectable | 1hxbA-2qkxA:15.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qzw | CANDIDAPEPSIN-1 (Candidaalbicans) |
PF00026(Asp) | 5 | ASP A 32GLY A 34ASP A 37GLY A 83ILE A 123 | None | 0.68A | 1hxbA-2qzwA:7.4 | 1hxbA-2qzwA:14.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rik | TITIN (Oryctolaguscuniculus) |
PF07679(I-set) | 5 | GLY A 175VAL A 127ILE A 119GLY A 120GLY A 121 | None | 0.86A | 1hxbA-2rikA:undetectable | 1hxbA-2rikA:18.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | AB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 ( 4.2A) | 0.46A | 1hxbA-2rkfA:21.0 | 1hxbA-2rkfA:86.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rsp | RSV PROTEASE (Rous sarcomavirus) |
PF00077(RVP) | 5 | ASP A 37GLY A 39ALA A 40ASP A 41ILE A 108 | None | 0.28A | 1hxbA-2rspA:13.1 | 1hxbA-2rspA:32.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x58 | PEROXISOMALBIFUNCTIONAL ENZYME (Rattusnorvegicus) |
PF00378(ECH_1)PF00725(3HCDH)PF02737(3HCDH_N) | 5 | GLY A 72VAL A 28GLY A 60GLY A 100ILE A 29 | NoneNoneCOA A 760 ( 4.0A)GOL A 770 ( 4.3A)None | 0.69A | 1hxbA-2x58A:undetectable | 1hxbA-2x58A:8.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ILE A 211GLY A 186GLY A 676ILE A 675ILE A 417 | None | 0.76A | 1hxbA-2xvgA:undetectable | 1hxbA-2xvgA:7.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zxh | TRNA URIDINE5-CARBOXYMETHYLAMINOMETHYL MODIFICATIONENZYME MNMG (Aquifexaeolicus) |
PF01134(GIDA)PF13932(GIDA_assoc) | 5 | GLY A 389ILE A 52GLY A 53GLY A 58ILE A 59 | None | 0.84A | 1hxbA-2zxhA:undetectable | 1hxbA-2zxhA:9.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bn6 | LACTADHERIN (Bos taurus) |
PF00754(F5_F8_type_C) | 5 | GLY A 6VAL A 138GLY A 72ILE A 74ILE A 62 | None | 0.70A | 1hxbA-3bn6A:undetectable | 1hxbA-3bn6A:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c2o | NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE (Saccharomycescerevisiae) |
PF01729(QRPTase_C)PF02749(QRPTase_N) | 5 | GLY A 141ALA A 140GLY A 258GLY A 257ILE A 274 | None | 0.85A | 1hxbA-3c2oA:undetectable | 1hxbA-3c2oA:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ce9 | GLYCEROLDEHYDROGENASE (Clostridiumacetobutylicum) |
PF13685(Fe-ADH_2) | 5 | ALA A 102ASP A 101GLY A 96GLY A 95ILE A 94 | PEG A 404 ( 4.7A)NoneEDO A 401 ( 3.8A)NoneNone | 0.71A | 1hxbA-3ce9A:undetectable | 1hxbA-3ce9A:15.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cj8 | 2,3,4,5-TETRAHYDROPYRIDINE-2,6-DICARBOXYLATEN-ACETYLTRANSFERASE (Enterococcusfaecalis) |
PF00132(Hexapep)PF08503(DapH_N)PF14602(Hexapep_2) | 5 | GLY A 112ALA A 113ILE A 145GLY A 146ILE A 109 | None | 0.84A | 1hxbA-3cj8A:undetectable | 1hxbA-3cj8A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cj8 | 2,3,4,5-TETRAHYDROPYRIDINE-2,6-DICARBOXYLATEN-ACETYLTRANSFERASE (Enterococcusfaecalis) |
PF00132(Hexapep)PF08503(DapH_N)PF14602(Hexapep_2) | 5 | GLY A 130ALA A 131ILE A 171GLY A 172ILE A 127 | None | 0.75A | 1hxbA-3cj8A:undetectable | 1hxbA-3cj8A:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dj4 | BIFUNCTIONAL PROTEINGLMU (Mycobacteriumtuberculosis) |
PF00132(Hexapep)PF12804(NTP_transf_3) | 5 | GLY A 334ALA A 335ILE A 366GLY A 367ILE A 331 | None | 0.81A | 1hxbA-3dj4A:undetectable | 1hxbA-3dj4A:15.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g7r | PUTATIVETRANSCRIPTIONALREGULATOR (Streptomycescoelicolor) |
PF00440(TetR_N) | 5 | GLY A 166ALA A 167VAL A 99GLY A 186ILE A 98 | NoneNoneNoneNoneEDO A 960 ( 4.8A) | 0.72A | 1hxbA-3g7rA:undetectable | 1hxbA-3g7rA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hx1 | SLR1951 PROTEIN (Synechocystissp. PCC 6803) |
PF00498(FHA) | 5 | GLY A 83VAL A 110ILE A 44GLY A 35ILE A 102 | None | 0.72A | 1hxbA-3hx1A:undetectable | 1hxbA-3hx1A:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kci | PROBABLE E3UBIQUITIN-PROTEINLIGASE HERC2 (Homo sapiens) |
PF00415(RCC1) | 5 | GLY A4099ALA A4098ILE A3991GLY A3992GLY A3993 | None | 0.64A | 1hxbA-3kciA:undetectable | 1hxbA-3kciA:13.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kkj | AMINE OXIDASE,FLAVIN-CONTAINING (Pseudomonassyringae groupgenomosp. 3) |
PF01593(Amino_oxidase)PF13450(NAD_binding_8) | 5 | GLY A 54ALA A 55ILE A 12GLY A 11GLY A 38 | FAD A 401 (-3.7A)FAD A 401 (-3.5A)NoneFAD A 401 (-2.9A)None | 0.85A | 1hxbA-3kkjA:undetectable | 1hxbA-3kkjA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l0i | DRRA (Legionellapneumophila) |
PF14860(DrrA_P4M) | 5 | GLY A 411ALA A 412GLY A 463ILE A 405ILE A 471 | None | 0.88A | 1hxbA-3l0iA:undetectable | 1hxbA-3l0iA:13.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lun | ULILYSIN (Methanosarcinaacetivorans) |
PF05572(Peptidase_M43) | 5 | ALA A 209ASP A 207VAL A 175ILE A 82ILE A 205 | None | 0.81A | 1hxbA-3lunA:undetectable | 1hxbA-3lunA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdo | PUTATIVEPHOSPHORIBOSYLFORMYLGLYCINAMIDINECYCLO-LIGASE (Parabacteroidesdistasonis) |
PF02769(AIRS_C) | 5 | GLY A 58ASP A 160ILE A 107GLY A 108ILE A 80 | NoneNoneACT A 395 (-4.3A)NoneNone | 0.84A | 1hxbA-3mdoA:undetectable | 1hxbA-3mdoA:15.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ALA A 28ASP A 29ASP A 30VAL A 32GLY A 48PRO A 81 | None | 0.89A | 1hxbA-3mwsA:19.6 | 1hxbA-3mwsA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32PRO A 81ILE A 84 | None | 0.61A | 1hxbA-3mwsA:19.6 | 1hxbA-3mwsA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29VAL A 32ILE A 47GLY A 48GLY A 49ILE A 50ILE A 84 | None | 0.41A | 1hxbA-3mwsA:19.6 | 1hxbA-3mwsA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29VAL A 32ILE A 47GLY A 48GLY A 49PRO A 81ILE A 84 | None | 0.44A | 1hxbA-3mwsA:19.6 | 1hxbA-3mwsA:77.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ogz | UDP-SUGARPYROPHOSPHORYLASE (Leishmaniamajor) |
PF01704(UDPGP) | 5 | GLY A 122ALA A 121ASP A 271ILE A 269ILE A 167 | None | 0.77A | 1hxbA-3ogzA:undetectable | 1hxbA-3ogzA:10.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slz | GAG-PRO-POLPOLYPROTEIN (Murine leukemiavirus) |
PF00077(RVP) | 5 | ASP A 32GLY A 34ALA A 35VAL A 39GLY A 56 | 3TL A 126 (-2.4A)3TL A 126 (-3.1A)3TL A 126 ( 4.0A)None3TL A 126 (-3.4A) | 0.60A | 1hxbA-3slzA:11.3 | 1hxbA-3slzA:27.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3swd | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Escherichiacoli) |
PF00275(EPSP_synthase) | 5 | GLY A 133ALA A 134GLY A 98ILE A 169ILE A 136 | None | 0.88A | 1hxbA-3swdA:undetectable | 1hxbA-3swdA:13.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 49ILE A 50 | 017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-3.5A)017 A 201 (-4.2A)NoneNone017 A 201 (-4.0A)017 A 201 (-3.3A) | 0.38A | 1hxbA-3t3cA:18.6 | 1hxbA-3t3cA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 29ASP A 30VAL A 32ILE A 47GLY A 49PRO A 81 | 017 A 201 (-3.5A)017 A 201 (-4.2A)NoneNone017 A 201 (-4.0A)None | 0.67A | 1hxbA-3t3cA:18.6 | 1hxbA-3t3cA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 50PRO A 81ILE A 84 | 017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)017 A 201 (-3.3A)017 A 201 (-4.1A)017 A 201 (-4.7A) | 0.61A | 1hxbA-3ttpA:19.6 | 1hxbA-3ttpA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | 017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)None017 A 201 (-3.0A)017 A 201 (-3.3A)017 A 201 (-4.1A)017 A 201 (-4.7A) | 0.49A | 1hxbA-3ttpA:19.6 | 1hxbA-3ttpA:78.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u0o | SELENIDE, WATERDIKINASE (Escherichiacoli) |
PF00586(AIRS)PF02769(AIRS_C) | 5 | GLY A 213ALA A 214ILE A 156GLY A 155ILE A 89 | None | 0.77A | 1hxbA-3u0oA:undetectable | 1hxbA-3u0oA:15.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25ALA A 28ASP A 29ASP A 30ILE A 47GLY A 48GLY A 49PRO A 81 | 017 A 202 ( 2.5A)017 A 201 (-3.4A)017 A 201 (-3.2A)017 A 201 ( 4.0A)017 A 202 (-3.6A)017 A 202 ( 4.6A)017 A 202 (-2.9A)017 A 202 (-4.0A) | 0.47A | 1hxbA-3u7sA:19.9 | 1hxbA-3u7sA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 48GLY A 49ILE A 50 | 017 A 202 ( 2.5A)017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 201 (-3.2A)017 A 201 ( 4.0A)017 A 202 (-3.6A)017 A 202 ( 4.6A)017 A 202 (-2.9A)017 A 201 ( 3.5A) | 0.44A | 1hxbA-3u7sA:19.9 | 1hxbA-3u7sA:78.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uhj | PROBABLE GLYCEROLDEHYDROGENASE (Sinorhizobiummeliloti) |
PF00465(Fe-ADH) | 5 | GLY A 116VAL A 172GLY A 266ILE A 149ILE A 135 | GOL A 487 (-3.9A)NoneNoneNoneNone | 0.78A | 1hxbA-3uhjA:undetectable | 1hxbA-3uhjA:15.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vnp | HYPOTHETICALCONSERVED PROTEIN (Geobacilluskaustophilus) |
PF00132(Hexapep) | 5 | ALA A 112ILE A 96GLY A 97GLY A 115ILE A 126 | None | 0.76A | 1hxbA-3vnpA:undetectable | 1hxbA-3vnpA:18.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bhd | SERINEHYDROXYMETHYLTRANSFERASE (Methanocaldococcusjannaschii) |
PF00464(SHMT) | 5 | ASP A 196GLY A 197ALA A 198GLY A 233GLY A 234 | None | 0.78A | 1hxbA-4bhdA:undetectable | 1hxbA-4bhdA:12.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f32 | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 2 (Burkholderiavietnamiensis) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | GLY A 97ALA A 96VAL A 7ILE A 10GLY A 11 | None | 0.76A | 1hxbA-4f32A:undetectable | 1hxbA-4f32A:14.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmg | VP1 (Humanpolyomavirus 5) |
PF00718(Polyoma_coat) | 5 | VAL A 311ILE A 168GLY A 169GLY A 170ILE A 55 | None | 0.75A | 1hxbA-4fmgA:undetectable | 1hxbA-4fmgA:16.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j8f | HEAT SHOCK 70 KDAPROTEIN 1A/1B,HSC70-INTERACTINGPROTEIN (Homo sapiens;Rattusnorvegicus) |
PF00012(HSP70) | 5 | GLY A 224ASP A 206ASP A 199GLY A 202GLY A 229 | NonePO4 A 603 ( 4.7A) MG A 602 ( 3.9A)ADP A 601 (-3.4A)None | 0.89A | 1hxbA-4j8fA:undetectable | 1hxbA-4j8fA:11.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jga | 3-OXOACYL-[ACYL-CARRIER-PROTEIN]SYNTHASE 2 (Rickettsiarickettsii) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | GLY A 276ALA A 301ASP A 304ILE A 273ILE A 184 | None | 0.88A | 1hxbA-4jgaA:undetectable | 1hxbA-4jgaA:11.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mzu | WXCM-LIKE PROTEIN (Shewanelladenitrificans) |
PF00132(Hexapep)PF05523(FdtA) | 5 | ALA A 103ILE A 73GLY A 74GLY A 106ILE A 117 | None | 0.79A | 1hxbA-4mzuA:undetectable | 1hxbA-4mzuA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mzu | WXCM-LIKE PROTEIN (Shewanelladenitrificans) |
PF00132(Hexapep)PF05523(FdtA) | 5 | ALA A 121ILE A 105GLY A 106GLY A 124ILE A 140 | None | 0.88A | 1hxbA-4mzuA:undetectable | 1hxbA-4mzuA:15.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ALA A 28ASP A 29ASP A 30VAL A 32GLY A 48PRO A 81ILE A 84 | RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)NoneRIT A 500 (-4.8A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.76A | 1hxbA-4njvA:20.2 | 1hxbA-4njvA:86.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32PRO A 81ILE A 84 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)NoneRIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.48A | 1hxbA-4njvA:20.2 | 1hxbA-4njvA:86.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ASP A 25GLY A 27ALA A 28ASP A 29VAL A 32ILE A 47GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)NoneRIT A 500 ( 4.5A)RIT A 500 (-4.8A)RIT A 500 (-3.4A)RIT A 500 (-4.3A)RIT A 500 (-3.9A)RIT A 500 (-4.3A) | 0.46A | 1hxbA-4njvA:20.2 | 1hxbA-4njvA:86.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p8r | GLYCERALDEHYDE3-PHOSPHATEDEHYDROGENASE,CYTOSOLIC (Trypanosomabrucei) |
PF00044(Gp_dh_N)PF02800(Gp_dh_C) | 5 | ALA A 21VAL A 5ILE A 326ILE A 13ILE A 29 | MG A 401 (-4.5A)NoneNoneNAD A 400 (-4.3A)None | 0.85A | 1hxbA-4p8rA:undetectable | 1hxbA-4p8rA:15.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qsl | PYRUVATE CARBOXYLASE (Listeriamonocytogenes) |
no annotation | 5 | GLY H 275ALA H 274VAL H 311GLY H 84ILE H 310 | None | 0.77A | 1hxbA-4qslH:undetectable | 1hxbA-4qslH:6.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r2b | EXTRACELLULARSOLUTE-BINDINGPROTEIN FAMILY 1 (Ochrobactrumanthropi) |
PF01547(SBP_bac_1) | 5 | GLY A 281ALA A 280GLY A 42GLY A 43ILE A 260 | None | 0.66A | 1hxbA-4r2bA:undetectable | 1hxbA-4r2bA:12.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 6 | ASP A 32GLY A 34ALA A 35ASP A 36GLY A 58ILE A 100 | 4B1 A 201 (-2.9A)4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)4B1 A 201 (-3.4A)4B1 A 201 (-4.8A) | 0.45A | 1hxbA-4ydfA:13.1 | 1hxbA-4ydfA:30.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 6 | ASP A 32GLY A 34ALA A 35ASP A 36VAL A 39ILE A 100 | 4B1 A 201 (-2.9A)4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)None4B1 A 201 (-4.8A) | 0.38A | 1hxbA-4ydfA:13.1 | 1hxbA-4ydfA:30.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48GLY A 49 | None | 0.85A | 1hxbA-5b18A:18.1 | 1hxbA-5b18A:75.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48ILE A 84 | None | 0.36A | 1hxbA-5b18A:18.1 | 1hxbA-5b18A:75.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49 | None | 0.67A | 1hxbA-5b18A:18.1 | 1hxbA-5b18A:75.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f42 | ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINEO-ACYLTRANSFERASE (Francisellatularensis) |
PF00132(Hexapep)PF13720(Acetyltransf_11) | 5 | ALA A 48ILE A 32GLY A 33GLY A 51ILE A 62 | None | 0.89A | 1hxbA-5f42A:undetectable | 1hxbA-5f42A:18.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5g5g | PUTATIVE XANTHINEDEHYDROGENASE YAGTIRON-SULFUR-BINDINGSUBUNIT (Escherichiacoli) |
PF00111(Fer2)PF01799(Fer2_2) | 5 | GLY A 211ALA A 212ASP A 154GLY A 159ILE A 216 | NoneNoneNoneFES A 230 (-4.2A)None | 0.80A | 1hxbA-5g5gA:undetectable | 1hxbA-5g5gA:24.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ihe | DNA POLYMERASE IISMALL SUBUNIT (Pyrococcusabyssi) |
PF00149(Metallophos) | 5 | GLY A 500ALA A 530GLY A 534GLY A 535ILE A 458 | NoneNoneNoneNoneACT A 705 (-3.9A) | 0.80A | 1hxbA-5iheA:undetectable | 1hxbA-5iheA:12.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5itg | SORBITOLDEHYDROGENASE (Gluconobacteroxydans) |
PF01232(Mannitol_dh)PF08125(Mannitol_dh_C) | 5 | GLY A 99ALA A 100ILE A 28GLY A 27PRO A 275 | None | 0.85A | 1hxbA-5itgA:undetectable | 1hxbA-5itgA:10.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jsz | CONSERVEDHYPOTHETICALMEMBRANE PROTEIN (Lactobacillusdelbrueckii) |
PF12822(ECF_trnsprt) | 5 | GLY C 64ALA C 65ASP C 68ILE C 83GLY C 84 | None | 0.89A | 1hxbA-5jszC:undetectable | 1hxbA-5jszC:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5odr | METHYL-VIOLOGENREDUCINGHYDROGENASE, SUBUNITAMETHYL-VIOLOGENREDUCINGHYDROGENASE, SUBUNITG (Methanothermococcusthermolithotrophicus) |
PF00374(NiFeSe_Hases)PF01058(Oxidored_q6) | 5 | GLY F 14ILE F 60GLY F 62ILE E 17PRO F 374 | NoneNoneNoneNoneNFU F 501 (-3.5A) | 0.86A | 1hxbA-5odrF:undetectable | 1hxbA-5odrF:11.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 49ILE A 50ILE A 84 | None | 0.48A | 1hxbA-5t2zA:20.2 | 1hxbA-5t2zA:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30VAL A 32ILE A 47GLY A 49PRO A 81ILE A 84 | None | 0.45A | 1hxbA-5t2zA:20.2 | 1hxbA-5t2zA:79.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux9 | CHLORAMPHENICOLACETYLTRANSFERASE (Aliivibriofischeri) |
PF00132(Hexapep) | 5 | GLY A 79ALA A 80ILE A 145GLY A 146ILE A 76 | None | 0.80A | 1hxbA-5ux9A:undetectable | 1hxbA-5ux9A:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xj1 | UNCHARACTERIZED RNAMETHYLTRANSFERASESP_1029 (Streptococcuspneumoniae) |
no annotation | 5 | GLY A 399ALA A 400ASP A 401ILE A 373ILE A 378 | None | 0.83A | 1hxbA-5xj1A:undetectable | 1hxbA-5xj1A:13.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ya1 | AUTOINDUCER-2 KINASE (Escherichiacoli) |
no annotation | 5 | GLY A 20ALA A 19GLY A 251GLY A 252ILE A 171 | None | 0.70A | 1hxbA-5ya1A:undetectable | 1hxbA-5ya1A:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z0c | NEROL DEHYDROGENASE (Persicariaminor) |
no annotation | 5 | GLY A 279VAL A 190GLY A 194GLY A 195ILE A 253 | NoneNoneBME A 405 ( 4.2A)BME A 405 (-3.3A)None | 0.83A | 1hxbA-5z0cA:undetectable | 1hxbA-5z0cA:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fiv | RETROPEPSIN (Felineimmunodeficiencyvirus) |
PF00077(RVP) | 5 | ASP A 30GLY A 32ALA A 33ASP A 34GLY A 58 | 3TL A 201 (-3.5A)3TL A 201 (-3.4A)3TL A 201 (-4.0A)3TL A 201 (-3.9A)3TL A 201 (-3.4A) | 0.25A | 1hxbA-6fivA:15.5 | 1hxbA-6fivA:29.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 48GLY A 49PRO A 81ILE A 84 | NIU A 100 (-2.8A)NIU A 100 (-4.5A)NIU A 100 (-3.6A)NoneNoneNoneNIU A 100 ( 3.8A)NoneNone | 0.61A | 1hxbA-6upjA:18.0 | 1hxbA-6upjA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 8 | GLY A 27ASP A 29ASP A 30GLY A 48GLY A 49ILE A 50PRO A 81ILE A 84 | NIU A 100 (-4.5A)NoneNoneNoneNIU A 100 ( 3.8A)NIU A 100 (-3.9A)NoneNone | 0.82A | 1hxbA-6upjA:18.0 | 1hxbA-6upjA:48.48 |